543916 — Hemant Surgical Industries Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual income statement for Hemant Surgical Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,036	1,091	1,056	1,066	2,318
Cost of Revenue
Gross Profit	219	287	274	301	533
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	989	995	958	984	2,101
Operating Profit	46.5	96.2	97.9	82.8	217
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	34	101	128	105	236
Provision for Income Taxes
Net Income After Taxes	27.2	76.4	98	80.4	182
Net Income Before Extraordinary Items
Net Income	27.2	76.4	98	80.4	182
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	27.2	76.4	98	80.4	182
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.6	7.32	9.84	8.43	14.9
Dividends per Share